Info

Neotropix was founded in late 2003 by pioneers in the field of oncolytic viruses and the inventor of nine patents in related fields. The company is dedicated to the development and commercialization of virus-based therapies to treat cancer and other diseases. Neotropix's highlighted products:- NTX010 - Cancer Fighting VirusNeotropix began operations in 2005 to develop and commercialize naturally derived, systemically deliverable oncolytic viruses for the treatment of solid tumors. By applying its proprietary screening process, called ViruScreen, to previously untapped viral resources, Neotropix has uncovered at least 19 entirely novel oncolytic candidates.